Skip to Content

Surface Oncology, Inc. (NASDAQ: SURF)

Securities Class Action

  • Date:
  • 8/6/2019
  • Company Name:
  • Surface Oncology, Inc.
  • Stock Symbol:
  • SURF
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

NEW YORK, August 26, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against Surface Oncology, Inc. (NYSE: SURF) on behalf of Surface Oncology  investors.  Our investigation concerns whether Surface Oncology has violated the federal securities laws and/or engaged in other unlawful business practices.

Our investigation concerns potential violations of federal securities laws pursuant to the company’s April 2019 initial public offering (“IPO”). On April 19, 2018 Surface Oncology held its IPO, offering shares at $15.00. Since it’s IPO, Surface Oncology stock has plummeted, and currently trades at just $2.22, or less than 15% of it’s IPO price.

If you purchased or otherwise acquired Surface Oncology shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Surface Oncology. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: